# Andy Round

> Andy Round is a funding round investor at Maven Capital Partners backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Maven Capital Partners](https://shizune.co/investors/profile/maven-capital-partners)
- Location: Manchester, United Kingdom
- Total investments: 2
- Last investment: Feb 2020
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/andy-round-7213ba8/
- Website: https://www.praeturaventures.com/team/

Andy Round is a funding round investor at Maven Capital Partners in Manchester focused on Medical and Health Care. Based in our Manchester office, Andy is responsible for the execution of new investments across the Maven funds and works with investee companies across the region. He joined Maven in March 2018 following 8 years of experience managing Regional funds for both SPARK Impact and MSIF. Andy has previously worked for IP-Group investing in a range ofearly stage University companies across different sectors. At Yet2 as Consulting Director Andy provided services for companies such as Sumitomo Chemical, DSM, P+G, Unilever and Philips. Andy has a PhD in Biochemistry from the University of Leeds, the technology developed was incorporated into a company called Micap which went onto to raise £40m and was admitted to AiM.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 2 | 100% |
| Medical Device | 2 | 100% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inotec AMD | Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. |  |  | Feb 19, 2020 |  |
| Natrox | Inotec AMD is a wound-care company that has developed Natrox:tm:, a device that produces a continuous flow of humidified oxygen and directs it to a specially-designed dressing, allowing oxygen to constantly refresh the wound.NATROX:tm: is a battery-powered medical device that produces a continuous flow of pure humidified oxygen from air anddirects it through a fine tube to a specially-designed Oxygen Delivery System (ODS), allowing the oxygen to constantly refresh the wound while allowing free passage of wound fluids (exudate) to pass away from the wound surface for absorption and retention in the normal way. | $9M | Venture - Series Unknown | Feb 19, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Boundary Capital Partners LLP](https://shizune.co/investors/profile/boundary-capital) — VC Fund, 2 deals together
- [Puhua Capital](https://shizune.co/investors/profile/puhua-capital) — VC Fund, 2 deals together
- [Amadeus Capital Partners](https://shizune.co/investors/profile/amadeus-capital-partners) — VC Fund, 1 deal together

## About Maven Capital Partners

VC Fund · Glasgow, United Kingdom

Maven Capital Partners was formed in 2009 following a management buyout of the private equity business of Aberdeen Asset Management PLC. Maven is now one of the UK’s leading private equity firms in the lower-mid market, specialising in investments in high-growth British companies. With a focus on innovation and value creation, Maven partners withvisionary entrepreneurs to build market-leading businesses, supporting a range of transaction types, including management buyouts, growth capital, buy-and-build projects, equity value release, and pre-IPO financing.Since 2009, Maven has also helped institutional, private client, and retail investors access private markets, including tax-efficient Venture Capital Trusts, deal-by-deal co-investment in private equity and property, and institutional buyout funds.

5 contacts available at Maven Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Andy Round | Investment Director | https://shizune.co/investors/profile/andy-round-6fc8 |
| Dave Furlong | Investment Director | https://shizune.co/investors/profile/dave-furlong |
| Gavin Bell | Investment Manager | https://shizune.co/investors/profile/gavin-bell |
| James Darlington | Investment Manager | https://shizune.co/investors/profile/james-darlington |
| Jock Gardiner | Partner | https://shizune.co/investors/profile/jock-gardiner |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Andy Round invest in?

Andy Round invests primarily in Medical, Health Care and Medical Device startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Andy Round last invest?

The most recent investment recorded for Andy Round closed in Feb 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co